Lazertinib (Oral Route)

Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

1. Lazcluze

Descriptions

Lazertinib is used in combination with amivantamab as a first-line treatment for non-small cell lung cancer (NSCLC) that is metastatic (cancer that has spread) or cannot be removed by surgery in patients who have an abnormal epidermal growth factor receptor (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). Your doctor will perform a test before you take this medicine.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

• Tablet